Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 4/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 5/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5576963 | 0.93 | DRD2 (0.35) | DRD2SLC6A3SLC6A2METAP2CA14 | |
| SCHEMBL5576790 | 0.90 | DRD2 (0.36) | DRD2SLC6A3SLC6A2METAP2CA14 | |
| SCHEMBL5576958 | 0.85 | DRD2 (0.36) | DRD2SLC6A3SLC6A2METAP2SCN9A | |
| SCHEMBL5335228 | 0.81 | DRD2 (0.35) | DRD2SLC6A3SLC6A2METAP2SCN9A | |
| SCHEMBL5329226 | 0.81 | ACHE (0.37) | METAP2CA14 | |
| SCHEMBL14513381 | 0.80 | PTGS1 (0.35) | DRD2SLC6A3CA14SCN9A | |
| SCHEMBL14513382 | 0.80 | ACKR3 (0.34) | DRD2SLC6A3SLC6A2SCN9A | |
| SCHEMBL5577157 | 0.78 | SLC2A1 (0.37) | DRD2SLC6A3SLC6A2METAP2 | |
| SCHEMBL5312226 | 0.78 | PTGS1 (0.36) | DRD2SLC6A3SLC6A2 | |
| SCHEMBL13987175 | 0.78 | ACHE (0.43) | DRD2SLC6A3SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007052831-A1 | PREVENTIVES/REMEDIES FOR URINARY DISTURBANCE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-05-10 | — | — | WO | disclosed |